Head-to-head · Verified July 2026

MEDVi vs TrimRx: which GLP-1 provider wins?

Two of the most-searched compounded GLP-1 providers, side by side. MEDVi wins on entry price and scale; TrimRx wins on flat pricing and pharmacy transparency. Here's the full breakdown.

Affiliate disclosure: Veritide earns a commission when readers start care through some provider links on this page, at no extra cost to you. Commissions never influence our scores or rankings — we do not sell placement. See our full disclosure and scoring methodology.

	MEDVi	TrimRx
Verification score	7.2	7.2
Semaglutide entry	$179 first mo, $299/mo after	$199/mo (flat)
Tirzepatide entry	$279–$349 start, $399+/mo	$349/mo (flat, all doses)
Pricing model	Intro month then step-up	Flat — no dose surcharge
Pharmacy	503A (Belmar named)	Casa Pharma RX, per-batch tested
Formats	Injectable + oral	Injectable + oral
Coverage	49 states	Most states
Trustpilot	4.4 (4,000+)	3.3–3.5 (700+)
Notable flag	Feb 2026 FDA warning (marketing)	Upfront multi-month billing complaints

The short answer

Verdict

Choose MEDVi if you want the lowest first-month cost, oral tablets, and the reassurance of a large, established platform. Choose TrimRx if you'll titrate to higher doses and want flat pricing that won't climb — and you're comfortable reading the multi-month billing terms carefully first.

Pricing: the real math

MEDVi's $179 first month is the headline, but it steps to $299/mo — so a 6-month semaglutide run is roughly $179 + (5 × $299) = $1,674. TrimRx's flat $199/mo over 6 months is $1,194, and multi-month plans drop it further. For anything beyond a trial, TrimRx's flat model usually wins on total cost. Full math in our cost breakdown.

Pharmacy & safety

TrimRx names its pharmacy (Casa Pharma RX) and discloses per-batch third-party testing, which is the stronger transparency posture. MEDVi is 503A and LegitScript-certified but received a February 2026 FDA warning letter over marketing claims — a compliance flag, not a product-quality finding. Both dispense compounded medications that are not FDA-approved as finished products.

We earn nothing from this review

Veritide has no affiliate relationship with TrimRx. We reviewed it anyway — a provider comparison that only covers companies that pay us is a catalog, not a review. That is why there is no button here. Read the full review →

MEDVi

Lowest first-month entry, oral options, large established platform.

Start Your Intake

FAQ

MEDVi or TrimRx — which is cheaper?

For a single trial month, MEDVi ($179) is cheaper. If you'll stay on treatment and titrate up, TrimRx's flat $199 (sema) / $349 (tirz) can total less than MEDVi's $299+ refills. Your expected duration decides it.

Which has better pharmacy sourcing?

TrimRx edges MEDVi here — it names Casa Pharma RX and discloses per-batch third-party sterility and potency testing. Both use 503A compounders; both are LegitScript-certified.

Which is more established?

MEDVi is larger (100,000+ patients, 4,000+ reviews at 4.4) and has more operating history. TrimRx is newer (2025) with a smaller, more polarized review base.

Medical disclaimer: Veritide is an independent consumer-research publication, not a healthcare provider or pharmacy. This page is informational and is not medical advice. Compounded medications are not FDA-approved as finished products. Always consult a licensed clinician before starting any peptide or GLP-1 therapy.